Literature DB >> 8376783

Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.

K S Anderson1, J Alexander, M Wei, P Cresswell.   

Abstract

Intracellular transport and stability of class I MHC glycoproteins depends on the assembly of H chain, beta 2-microglobulin, and peptide. The Ag processing mutant cell lines T2 and RMA-S have defects in peptide loading of class I, resulting in reduced cell surface expression of class I molecules. Expression of class I molecules in the murine cell line RMA-S can be induced at 26 degrees C, suggesting that they are transported to the cell surface, but are unstable. However, most human class I molecules in T2 are poorly expressed at the cell surface, even at 26 degrees C. To directly compare the transport of human and mouse alleles in RMA-S and T2, the human alleles HLA-A2, A3, and B27 were transfected into RMA-S along with human beta 2-microglobulin, and the mouse alleles H-2Kb and Db were transfected into T2. Surface expression of HLA-A3 and B27 in RMA-S remained less than 10% of wild-type levels at 26 degrees C. H-2Kb and Db in both cell lines, however, were expressed at 20 to 30% wild-type levels at 37 degrees C and could be induced to wild-type levels at 26 degrees C or with peptides. The selective expression of murine class I glycoproteins at the cell surface of T2 is not because of their greater stability when associated with human beta 2m, since H-2Kb and Db H chain/human beta 2m complexes dissociate more rapidly in vitro than HLA-A3 and B27 complexes. These results suggest that the difference in transport between human and mouse class I in T2 reflects a fundamental structural property of the class I glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376783

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.

Authors:  Hong Shen; Anne L Ackerman; Virginia Cody; Alessandra Giodini; Ella R Hinson; Peter Cresswell; Richard L Edelson; W Mark Saltzman; Douglas J Hanlon
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

2.  The redox activity of ERp57 is not essential for its functions in MHC class I peptide loading.

Authors:  David R Peaper; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

3.  Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.

Authors:  J E Gairin; H Mazarguil; D Hudrisier; M B Oldstone
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

5.  Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

Authors:  M T Esser; J W Bess; K Suryanarayana; E Chertova; D Marti; M Carrington; L O Arthur; J D Lifson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carlos Vilches; François A Lemonnier; Arie Admon; Daniel López
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

7.  A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88.

Authors:  Peter Ross; Jennifer C Holmes; Gregory S Gojanovich; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2012-09-21       Impact factor: 2.046

Review 8.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

9.  NetCTLpan: pan-specific MHC class I pathway epitope predictions.

Authors:  Thomas Stranzl; Mette Voldby Larsen; Claus Lundegaard; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-04-09       Impact factor: 2.846

10.  Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines.

Authors:  Craig L Slingluff; Galina V Yamshchikov; Kevin T Hogan; Sarah C Hibbitts; Gina R Petroni; Eric A Bissonette; James W Patterson; Patrice Y Neese; William W Grosh; Kimberly A Chianese-Bullock; Andrea Czarkowski; Patrice K Rehm; Jayashree Parekh
Journal:  Ann Surg Oncol       Date:  2008-10-16       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.